ADAR1 Capital Management »

Sagimet Biosciences Inc-a shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.4M 438k 7.73

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Zai Lab Adr (ZLAB)
Agios Pharmaceuticals (AGIO)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Anteris Technologies Global (AVR)
Editas Medicine (EDIT)
Denali Therapeutics (DNLI)
Spyre Therapeutics Com New (SYRE)

View all positions for ADAR1 Capital Management

Top funds holding Sagimet Biosciences Inc-a

Vanguard Capital Management
Affinity Asset Advisors
Federated Investors
Dr. Jeffrey R. Jay, M.D.
Blue Owl Capital Holdings
Woodline Partners
Baker Bros. Advisors
Millennium Management
Standard Life Aberdeen
BlackRock
Goldman Sachs Group
Hillhouse Capital Advisors
ADAR1 Capital Management
Vanguard Portfolio Management
Vanguard Fiduciary Trust

View all funds holding Sagimet Biosciences Inc-a